High mitochondrial DNA levels accelerate lung adenocarcinoma progression

Area of Science:

• Oncology
• Mitochondrial Biology
• Cancer Genetics

Background:

• Lung adenocarcinoma is an aggressive cancer with high mortality.
• Mitochondrial DNA (mtDNA) copy number alterations are observed in various cancers.
• The specific role of mtDNA copy number in lung adenocarcinoma progression remains unclear.

Purpose of the Study:

• To investigate the in vivo role of mitochondrial DNA copy number in lung adenocarcinoma progression.
• To determine if increased mtDNA copy number causally affects tumor growth.
• To explore the relevance of mtDNA copy number in human lung cancer.

Main Methods:

• Induction of lung tumors in mice with KRASG12D expression.
• Generation of transgenic mice with elevated mtDNA copy number.
• Experimental depletion of mtDNA in tumor cells.
• Analysis of tumor burden, mitochondrial respiration, immune cell populations, and plasma cytokine levels.
• Bioinformatic analysis of human lung cancer databases.

Main Results:

• KRASG12D-induced lung tumors exhibited increased mtDNA levels and enhanced mitochondrial respiration.
• Mice with elevated mtDNA copy number developed a larger tumor burden.
• mtDNA depletion in tumor cells significantly reduced tumor growth.
• Increased mtDNA levels did not affect lung immune cell populations or plasma cytokine levels.
• Human lung cancer data corroborated the importance of mtDNA copy number.

Conclusions:

• mtDNA copy number plays a critical tumor-intrinsic role in lung adenocarcinoma progression.
• Elevated mtDNA copy number promotes tumor growth, while its depletion inhibits it.
• mtDNA copy number represents a potential therapeutic target for lung cancer.